Metaplastic breast cancer: Prognosis and response to systemic therapy

Annals of Oncology

Volumn 10, Issue 4, 1999, Pages 413-419

  Rayson, D ^a,b   Adjei, A A ^a   Suman, V J ^a   Wold, L E ^a   Ingle, J N ^a  

^a MAYO CLINIC   (United States)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Metaplastic breast cancer; Prognosis; Systemic therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; METAPLASIA; METAPLASTIC BREAST CANCER; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; METAPLASIA; METHOTREXATE; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; PALLIATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TAMOXIFEN; TREATMENT OUTCOME;

EID: 0032961242     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008329910362     Document Type: Article

References (24)

1. Rosen PP. Rosen's Breast Pathology. Philadelphia: Lippencott-Raven 1997; 375-95.
2. Tavassoli FA. Classification of metaplastic carcinomas of the breast. Pathol Annu 27 Pt 1992; 2: 89-119.
3. Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol 1989; 20: 732-40.
4. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 1989; 20: 628-35.
5. Gutman H, Pollock RE, Janjan NA et al. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 1995; 180: 193-9.
6. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989; 64: 1490-9.
7. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
8. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52: 203-23.
9. Oberman HA. Metaplastic carcinoma of the breast. A clinico-pathologic study of 29 patients. Am J Surg Pathol 1987; 11 (12): 918-29.
10. Kaufman MW, Marti JR, Gallager S et al. Carcinoma of the breast with pseudosarcomatous metaplasia. Cancer 1984; 53: 1908-17.
11. Pitts WC, Rojas VA, Gaffey MJ et al. Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol 1991; 95: 623-32.
12. Johnson TL, Kini SR. Metaplastic breast carcinoma: A cytohistologic and clinical study of 10 cases. Diag Cytopathol 1996; 14: 226-32.
13. Flint A, Oberman HA, Davenport RD. Cytophotometric measurements of metaplastic carcinoma of the breast: Correlation with pathologic features and clinical behavior. Mod Pathol 1988; 1: 193-7.
14. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast IV. squamous cell carcinoma of ductal origin. Cancer 1990; 65: 272-6.
15. Huvos AG, Lucas JC, Foote FW. Metaplastic breast carcinoma. NY Stat J Med 1973; 73: 1078-82.
16. Smith BH, Taylor HB. The occurrence of bone and cartilage in mammary tumors. Am J Clin Pathol 1969; 51: 610-8.
17. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1969; 63: 181-7.
18. Nemoto T, Natarjian N, Bedwani R et al. Breast cancer in the medial half: Results of the 1978 national survey of the American College of Surgeons. Cancer 1983; 51: 1333-8.
19. Albain KS, Allred C, Clark GM. Breast cancer outcome and predictors of outcome: Are there age differentials? Monogr Natl Cancer Inst 1994; 6: 35-42.
20. Nixon AJ, Neuberg D, Hayes DF et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12: 888-94.
21. Harris JR, Hellman S. Natural history of breast cancer. In Harris JR, Lippman ME, Morrow M, Hellman S (eds.): Diseases of the Breast. Philadelphia, PA: Lippencott-Raven 1996; 375-91.
22. Honig SF. Treatment of metastatic disease. In Harris JR, Lippman ME, Morrow M, Hellman S (eds.): Diseases of the Breast. Philadelphia: Lippencott-Raven 1996; 669-734.
23. Perez JE, Machiavelli M, Leone BA et al. Bone-only versus visceral-only metastatic pattern in breast cancer: Analysis of 150 patients. Am J Clin Oncol 1990; 13 (4): 294-8.
24. Sherry MM, Greco FA, Johnson DH et al. Metastatic breast cancer confined to the skeletal system, an indolent disease. Am J Med 1986; 81: 381-6.